Skip to main content
Veterinary Medicines

Selehold 45 mg spot-on solution for cats 2.6–7.5 kg

Authorised
  • Selamectin

Product identification

Medicine name:
Selehold 45 mg spot-on solution for cats 2.6–7.5 kg
Selehold 45 mg voor katten 2,6 - 7,5 kg 60 mg/ml Spot-on oplossing
Selehold 45 mg pour chats 2,6 - 7,5 kg 60 mg/ml Solution pour spot-on
Selehold 45 mg fur Katzen 2,6 - 7,5 kg 60 mg/ml Lösung zum Auftropfen
Active substance:
  • Selamectin
Target species:
  • Cat
Route of administration:
  • Spot-on use

Product details

Active substance and strength:
  • Selamectin
    45.00
    milligram(s)
    /
    1.00
    Pipette
Pharmaceutical form:
  • Spot-on solution
Withdrawal period by route of administration:
  • Spot-on use
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP54AA05
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Package description:
  • Translucent polypropylene unit-dose pipette with polyethylene or polyoxymethylene or polypropylene closure with spikepackaged into a laminated triplex bag composed of polyester, aluminium and polyethylene. 3 ml pipette containing 0.75 ml of solution.Cardboard box containing 1 pipette.
  • Translucent polypropylene unit-dose pipette with polyethylene or polyoxymethylene or polypropylene closure with spikepackaged into a laminated triplex bag composed of polyester, aluminium and polyethylene. 3 ml pipette containing 0.75 ml of solution.Cardboard box containing 3 pipettes.
  • Translucent polypropylene unit-dose pipette with polyethylene or polyoxymethylene or polypropylene closure with spikepackaged into a laminated triplex bag composed of polyester, aluminium and polyethylene. 3 ml pipette containing 0.75 ml of solution.Cardboard box containing 6 pipettes.
  • Translucent polypropylene unit-dose pipette with polyethylene or polyoxymethylene or polypropylene closure with spikepackaged into a laminated triplex bag composed of polyester, aluminium and polyethylene. 3 ml pipette containing 0.75 ml of solution.Cardboard box containing 15 pipettes.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • KRKA tovarna zdravil d.d. Novo mesto
Marketing authorisation date:
Manufacturing sites for batch release:
  • TAD Pharma GmbH
  • KRKA tovarna zdravil d.d. Novo mesto
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V537893
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0394/002
Concerned member states:
  • Belgium
  • Bulgaria
  • Croatia
  • Czechia
  • Estonia
  • France
  • Germany
  • Greece
  • Hungary
  • Italy
  • Latvia
  • Lithuania
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Download
Dutch (PDF)
Published on: 22/11/2024
French (PDF)
Published on: 22/11/2024
German (PDF)
Published on: 22/11/2024

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 22/11/2024
French (PDF)
Published on: 22/11/2024
German (PDF)
Published on: 22/11/2024

Labelling

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 22/11/2024
French (PDF)
Published on: 22/11/2024
German (PDF)
Published on: 22/11/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."